Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4973 total record number 1 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 57 out of 498
4973 citations found

CARD-only proteins regulate invivo inflammasome responses and ameliorate gout

Devi, S;Indramohan, M;Jäger, E;Carriere, J;Chu, LH;de Almeida, L;Greaves, DR;Stehlik, C;Dorfleutner, A;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Post-injury born oligodendrocytes incorporate into the glial scar and contribute to the inhibition of axon regeneration

Xing, J;Lukomska, A;Rheaume, BA;Kim, J;Sajid, MS;Damania, A;Trakhtenberg, EF;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Glycopolymer-conjugated antigens as an inverse vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy

Cao, S;Maulloo, C;Raczy, M;Sabados, M;Slezak, A;Nguyen, M;Solanki, A;Wallace, R;Shim, H;Wilson, D;Hubbell, J;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation

Chen, X;Liu, L;Kang, S;Gnanaprakasam, JR;Wang, R;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2

Phan, JM;Layton, ED;Yu, KKQ;Aguilar, MS;Golez, I;Franko, NM;Logue, JK;Rodda, LB;Howard, CA;Pepper, M;Gale, M;Chu, HY;Seshadri, C;

Product: Enterotoxin Type B from Staphylococcus aureus

  • Intracellular cytokine staining

    … Cells were plated at a density of 1 × 106 cells/well in a 96-well U-bottom plate and stimulated at 37°C with either 1 μg/ml of each peptide in the pool, 0.25 μg/ml staphylococcal enterotoxin type B (List Biological Laboratories), or 0.2% DMSO (Sigma-Aldrich). After 6 h, stimulations were stopped by adding EDTA at a final concentration of 2 mM, and samples were stored overnight at 4°C.

Loss of biased signaling at a G protein-coupled receptor in overexpressed systems

Li, A;Liu, S;Huang, R;Ahn, S;Lefkowitz, RJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Memory Th1 cells modulate heterologous diseases through innate function

Rakebrandt, N;Yassini, N;Kolz, A;Schorer, M;Lambert, K;Rauld, C;Balazs, Z;Krauthammer, M;Carballido, J;Peters, A;Joller, N;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes

Yu, C;Ruan, Y;Sun, X;Chen, C;Shen, T;Liu, C;Qiu, W;Lu, Z;Chan, SO;Wang, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

A spinal synergy of excitatory and inhibitory neurons coordinates ipsilateral body movements

Hayashi, M;Gullo, M;Senturk, G;Di Costanzo, S;Nagasaki, SC;Kageyama, R;Imayoshi, I;Goulding, M;Pfaff, SL;Gatto, G;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo

Jansen, A;Waalders, NJB;van Lier, DPT;Kox, M;Pickkers, P;

Product: LIST™ HPT™ from Escherichia coli O113

  • Experimental human endotoxemia

    All endotoxemia-related procedures were performed according to our standard continuous LPS-infusion protocol (12). In short, subjects were admitted to the research unit situated on the Medium Care department of the Radboud university medical center for approximately ten hours. Subjects had to refrain from consumption of alcohol and caffeine (24 h), and food and drinks (12 h) prior to LPS administration. Upon admission on the first LPS challenge day, two antebrachial venous cannulas were placed to allow administration of fluids, study medication and LPS. A radial artery catheter (BD Infusion Therapy Systems, Sandy, Utah, USA) was placed under ultrasound guidance to allow serial blood sampling and continuous hemodynamic monitoring. To reduce the risk of vasovagal responses (14), hydration fluids (2.5% glucose/0.45% sodium chloride) were administered as an initial prehydration bolus of 1.5L in the 45 min prior to LPS administration, and at a rate of 150 mL/hr for the remainder of the experiment. After prehydration, a bodyweight adjusted bolus dose of 1 ng/kg LPS (E. coli type O:113, lot no. 94332B1; List Biological Laboratories, Campbell, USA) was administered intravenously, directly followed by continuous infusion of LPS at a rate of 0.5 ng/kg/hr for three hours. Blood samples were serially obtained to construct time-concentration curves of circulating cytokines. Heart rate and intra-arterial blood pressure were measured using a 4-lead electrocardiogram (M50 Monitor, Philips, Eindhoven, the Netherlands) and a radial artery pressure transducer (Edwards Lifesciences, Irvine, California, USA). Hemodynamic parameters were recorded every 5 s using in-house developed software. Every 30 min, body temperature was measured using a tympanic thermometer (FirstTemp Genius 2, Covidien, Dublin, Ireland). Flu-like symptoms (headache, nausea, cold shivers, myalgia and back pain) were scored every 30 min using a numeric six-point Likert scale (0 = no symptoms, 5 = worst ever experienced). A composite score was then calculated as the sum of all previous elements, resulting in a total symptom score ranging from 0 to 25. Furthermore, general malaise was scored on an eleven-point scale (0 = no symptoms, 10 = worst ever experienced).

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113